Fabio Conforti, medical oncologist1, Laura Pala, medical oncologist1, Isabella Sala, masters student in statistics2, Chiara Oriecuia, doctoral student in statistics3, Tommaso De Pas, medical oncologist1, Claudia Specchia, professor of statistics4,…
Tag: Neoadjuvant
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients
Summary Background Previous studies have independently validated the prognostic relevance of residual cancer burden (RCB) after neoadjuvant chemotherapy. We used results from several independent cohorts in a pooled patient-level analysis…
Patient Race Doesn’t Significantly Impact Pathological CR After Neoadjuvant Therapy for Breast Cancer
Although significant disparities for a subgroup of women who did not achieve a pathologic complete response (pCR) were observed, patient race did not significantly impact pCR and event-free survival (EFS)…